C00-C97
Conditions
Interventions
Group 1: Intervention Group
After diagnosis, patients are screened to verify the inclusion and exclusion criteria for the study. For enrollment in the study, Test Time 0 (T0) is then performed with ba
Sponsors
Uniklinik Köln
Eligibility
Sex/Gender
All
Age
6 Years to 17 Years
Inclusion criteria
Inclusion criteria: ? Pediatric oncology patients (ICD10 C00-C97) who are undergoing inpatient and outpatient treatment at the Pediatric Oncology and Hematology Department of the University Hospital Cologne and are receiving systemic therapy ? New or recurrent diagnosis of a malignant disease with the need for intensive oncological therapy ? Patients with a curative and palliative treatment approach ? Diagnosis of the malignant disease was made no more than 12 weeks ago ? Oncological intensive therapy with a minimum duration of 3 months ? Age at inclusion = 6-17 years ? From the point of view of the treating physicians, participation in the study is possible ? Existence of the declaration of consent for study participation from the legal guardians and, depending on age, that of the patients
Exclusion criteria
Exclusion criteria: ? Failure to meet the inclusion criteria ? Patient reaches the age of 18 in the next 3 months ? Isolated surgery without complementary systemic therapy ? Functional and/or cognitive impairment and/or orthopaedic complaints that do not allow participation in sports and exercise therapy ? Clinically manifest heart failure ? Partial or global respiratory insufficiency ? Symptomatic coronary heart disease ? Severe refractory hypertension ? Therapy-refractory thrombocytopenia < 10,000/µl ? Congenital or acquired thrombocytopathies or coagulation disorders ? Uncontrolled cerebral seizure disorder ? Physical or mental condition which, in the opinion of the investigator, does not permit sporting activity ? Participation in another sports/exercise study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary endpoint: Objectively measured physical activity Measured with: Accelerometer (Movisens) When: before the start of the intervention (T0) and after 3 months (end of intervention, T1) | — |
Secondary
| Measure | Time frame |
|---|---|
| Physical Fitness, Mental Health, Feasibility, Adherence | — |
Countries
Germany
Contacts
Public ContactThorsten Simon
Uniklinik Köln
Outcome results
None listed